Skip to search formSkip to main contentSkip to account menu

T 30177

Known as: T30177, T-30177, AR 177 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Resistance to raltegravir (RAL), the first HIV-1 integrase (IN) inhibitor approved by the FDA, involves three genetic pathways… 
2000
2000
AR177 (Zintevir) is a 17-mer oligonucleotide that has been shown to have anti-HIV activity and to be a potent HIV-1 integrase… 
1999
1999
Negatively charged albumins (NCAs) have been identified as potent inhibitors of HIV-1 replication in vitro. Time of addition… 
Review
1999
Review
1999
  • A. Field
  • 1999
  • Corpus ID: 33559561
Inhibition of human immunodeficiency virus (HIV) replication by oligonucleotides is a complex process and may be implemented by… 
Highly Cited
1998
Highly Cited
1998
The human immunodeficiency virus (HIV) inhibitor AR177 (T30177, Zintevir) has been identified as a potent inhibitor of HIV… 
Highly Cited
1997
Highly Cited
1997
Oligonucleotides that can form a highly stable intramolecular four-stranded DNA structure containing two stacked guanosine… 
Highly Cited
1996
Highly Cited
1996
We have identified a potentially therapeutic anti-human immunodeficiency virus (HIV)-1 oligonucleotide composed entirely of… 
1996
1996
Clinical trials of an HIV integrase inhibitor, Aronex Pharmaceuticals' AR-177, are in progress at San Francisco General… 
Highly Cited
1995
Highly Cited
1995
T30177, an oligonucleotide composed of only deoxyguanosine and thymidine, is 17 nucleotides in length and contains single…